Mesothelioma Treatment Costs Quick Reference
Mesothelioma Treatment Costs Quick Reference
Executive Summary
Mesothelioma treatment ranks among the most expensive of any cancer, with total lifetime costs ranging from $400,000 to more than $1 million depending on the treatment plan.[1][2] The single largest expense is first-line immunotherapy (Opdivo + Yervoy), which totals approximately $292,319 for a full course, while surgery ranges from $53,993 for pleurectomy/decortication (P/D) to $62,408 for extrapleural pneumonectomy (EPP), and a six-cycle chemotherapy regimen runs $38,779 to $87,741; the mean cost per hospitalization is $24,901, and patients typically require several.[3][1] Several financial-assistance pathways offset these costs: more than $30 billion remains available across 60+ asbestos trust funds, and the Inflation Reduction Act caps Medicare Part D out-of-pocket drug spending at $2,000 per year.[4][5] Patients and families should weigh insurance coverage, trust-fund claims, and legal compensation together, because these channels are independent and can be pursued in parallel.[2]
Overview
Mesothelioma treatment is among the most expensive of any cancer diagnosis, with total lifetime costs frequently exceeding $400,000 and reaching $1 million or more.[1] The mean cost per mesothelioma hospitalization is $24,901 based on national hospital discharge data, and patients typically require multiple hospitalizations over the course of treatment.[1] Since the 2020 FDA approval of immunotherapy (Opdivo + Yervoy) as a first-line treatment, average per-patient costs have increased substantially, with the immunotherapy treatment course alone totaling $292,319.[3] Multiple financial assistance programs — including $30+ billion in asbestos trust funds — can help offset these expenses.[4]
At a Glance
- Total lifetime cost — $400,000 to $1,000,000+ depending on treatment approach[1][2]
- Mean hospitalization cost — $24,901 per episode, with multiple hospitalizations typical[1]
- Immunotherapy (Opdivo + Yervoy) — $292,319 for the full first-line treatment course[3]
- Most expensive surgery (EPP) — $62,408 per procedure[1]
- Standard chemotherapy (6 cycles) — $38,779 to $87,741 in drug costs[1]
- Radiation therapy — $7,500 to $11,100 median per course[6]
- Bankruptcy risk — cancer patients are 2.65 times more likely to file[7]
- Medicare Part D out-of-pocket cap — $2,000 per year under the Inflation Reduction Act[5]
- Asbestos trust funds available — $30+ billion across 60+ trusts to help offset costs[4]
Key Facts
| Category | Detail |
|---|---|
| Total Lifetime Cost | $400,000–$1,000,000+[1][2] |
| Mean Hospitalization Cost | $24,901 per episode (2014)[1] |
| Most Expensive Standard Treatment | Immunotherapy: $292,319 total course[3] |
| Most Expensive Surgery | EPP: $62,408 per procedure[1] |
| Standard Chemotherapy (6 cycles) | $38,779–$87,741[1] |
| Radiation Per Course | $7,500–$11,100 median[6] |
| Bankruptcy Risk | Cancer patients 2.65× more likely to file[7] |
| Medicare Part D OOP Cap | $2,000/year (Inflation Reduction Act, 2025)[5] |
| Trust Fund Assets Available | $30+ billion across 60+ trusts[4] |
| Clinical Trial Participation | Less than 5% of mesothelioma patients[8] |
Treatment Cost Comparison
| Treatment | Cost | Measurement |
|---|---|---|
| EPP Surgery | $62,408 | Per procedure[1] |
| P/D Surgery | $53,993 | Per procedure[1] |
| CRS/HIPEC | $38,369 | Average hospital cost[9] |
| Pemetrexed + Cisplatin | $38,779 | 6 cycles drug cost[1] |
| Pemetrexed + Cisplatin + Bevacizumab | $87,741 | 6 cycles drug cost[1] |
| Opdivo + Yervoy | $292,319 | Total treatment course[3] |
| Radiation Therapy | $9,000 | Median per course[6] |
| CAR-T Cell Therapy | $300,000–$475,000 | Per infusion (experimental)[10] |
| TTFields (Optune Lua) | ~$21,000 | Per month[11] |
Frequently Asked Questions
How much does mesothelioma treatment cost?
Total lifetime costs typically range from $400,000 to over $1 million, depending on treatment approach. The mean cost per hospitalization is $24,901, with surgical cases averaging $29,344.[1] Immunotherapy with Opdivo plus Yervoy totals $292,319 over the treatment course.[3]
Does insurance cover mesothelioma treatment?
Most health insurance plans cover standard mesothelioma treatments, though patients face deductibles averaging $1,787 for employer plans.[12] Medicare covers hospice care with no deductible and caps Part D prescription costs at $2,000 per year under the Inflation Reduction Act.[5][13]
What financial help is available for mesothelioma patients?
Patients may access asbestos trust funds ($100,000–$400,000+ combined), personal injury lawsuits, VA disability benefits, SSDI through Compassionate Allowances, and manufacturer assistance programs.[14][4]
Do treatment costs vary by location?
Yes. Northeast U.S. hospitalizations average $33,396, compared to $18,206 in the Midwest — a difference of 83%.[1] U.S. treatment costs are also substantially higher than in most other developed nations.[1]
Can clinical trials reduce treatment costs?
Clinical trial sponsors typically cover investigational drug costs, and insurance must cover routine care under the ACA. However, less than 5% of mesothelioma patients currently participate in clinical trials.[8][15]
Quick Statistics
- Total lifetime mesothelioma treatment costs range from $400,000 to $1,000,000+[1][2]
- Mean hospitalization cost is $24,901 based on 1,675 hospital discharges nationally[1]
- Immunotherapy (Opdivo + Yervoy) costs $292,319 over the full treatment course[3]
- Cancer patients are 2.65 times more likely to file for bankruptcy than non-cancer patients[7]
- Northeast hospital costs are 83% higher than Midwest costs for mesothelioma[1]
- More than $30 billion remains in asbestos trust funds for mesothelioma patients[4]
- 35% of cancer caregivers report stopping work due to caregiving demands[16]
- Less than 5% of mesothelioma patients participate in clinical trials[8]
- Medicare Part D caps prescription out-of-pocket costs at $2,000/year under the Inflation Reduction Act[5]
External Links
- Danziger & De Llano — case evaluation on mesothelioma compensation and trust fund claims
- Mesothelioma Lawyers Near Me — attorney search
- Mesothelioma.net — patient resources, treatment information, and financial assistance guides
Related Pages
- Mesothelioma Treatment Costs — Comprehensive treatment cost breakdown
- Treatment Options — Overview of all mesothelioma treatments
- Asbestos Trust Funds — Trust fund compensation guide
- Mesothelioma Settlements — Settlement values and process
- Mesothelioma Treatment Centers — Specialized treatment facilities
- Clinical Trials — Current mesothelioma research trials
References
- ↑ 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 1.12 1.13 1.14 1.15 1.16 1.17 1.18 1.19 1.20 1.21 Borrelli EP, McGladrigan CG, et al. "Costs of medical care for mesothelioma." Rare Tumors. 2019;11:2036361319863498. https://pmc.ncbi.nlm.nih.gov/articles/PMC6637828/
- ↑ 2.0 2.1 2.2 2.3 2.4 Mesothelioma Treatment Costs, Mesothelioma Lawyer Center.
- ↑ 3.0 3.1 3.2 3.3 3.4 3.5 3.6 Gao L, Wang J, et al. "Cost-effectiveness of nivolumab plus ipilimumab as first-line therapy for unresectable malignant pleural mesothelioma." Front Public Health. 2022;10:947221. https://pmc.ncbi.nlm.nih.gov/articles/PMC9354521/
- ↑ 4.0 4.1 4.2 4.3 4.4 4.5 U.S. Government Accountability Office. "Asbestos Injury Compensation: The Role and Administration of Asbestos Trusts." GAO-11-819, September 2011. https://www.gao.gov/products/gao-11-819
- ↑ 5.0 5.1 5.2 5.3 5.4 Centers for Medicare & Medicaid Services. Medicare Part D out-of-pocket cap under the Inflation Reduction Act. https://www.cms.gov/inflation-reduction-act-and-medicare
- ↑ 6.0 6.1 6.2 Paravati AJ, Mell LK, et al. "Variation in the Cost of Radiation Therapy Among Medicare Patients with Cancer." J Oncol Pract. 2015;11(5):403-409. https://pmc.ncbi.nlm.nih.gov/articles/PMC4575405/
- ↑ 7.0 7.1 7.2 Zafar SY. "Financial toxicity of cancer care: it's time to intervene." J Natl Cancer Inst. 2016;108(5):djv370. https://pmc.ncbi.nlm.nih.gov/articles/PMC5985271/
- ↑ 8.0 8.1 8.2 Taioli E, Wolf AS, et al. "Patterns of Care and Survival Among Patients with Malignant Mesothelioma in the United States." Lung Cancer. 2018;115:55-60. https://pmc.ncbi.nlm.nih.gov/articles/PMC5726440/
- ↑ Naffouje SA, O'Donoghue C, Salti GI. Evaluation of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a community hospital setting. J Surg Oncol. 2016;113(4):461-466. PMID 26750613. PubMed
- ↑ American Cancer Society. "CAR T-cell Therapy and Its Side Effects." https://www.cancer.org/cancer/managing-cancer/treatment-types/immunotherapy/car-t-cell.html
- ↑ Mesothelioma Treatment Options, Mesothelioma.net.
- ↑ Kaiser Family Foundation. "2024 Employer Health Benefits Survey." https://www.kff.org/health-costs/report/2024-employer-health-benefits-survey/
- ↑ Medicare.gov. "Medicare and Hospice Benefits: Getting Started." https://www.medicare.gov/publications/11361-medicare-hospice-getting-started.pdf
- ↑ Danziger & De Llano, LLP, Mesothelioma Attorneys.
- ↑ Mesothelioma Treatment, Mesothelioma Lawyer Center.
- ↑ Yoon J, Chee CP, et al. "Working, Low Income, and Cancer Caregiving: Financial and Mental Health Impacts." JCO Oncol Pract. 2023;19(8):e1249-e1260. https://pmc.ncbi.nlm.nih.gov/articles/PMC10414725/
This quick reference page is maintained by WikiMesothelioma.com and updated as treatment costs change. Last reviewed: March 2026.